E
Enlitic
Biotech & Life Sciences · San Francisco, United States · Founded 2014 · IPO 2024
A modern machine learning company dedicated to revolutionizing diagnostic healthcare MoreLess
Enlitic is a technology company specializing in artificial intelligence (AI) solutions for the healthcare industry. The company develops both clinical and non-clinical AI-powered workflow solutions aimed at enterprise health systems. Enlitic's core product, Curie, is a platform that standardizes data and integrates seamlessly into existing health system infrastructures. This platform provides a range of AI-powered solutions for reading, reporting, quality assurance (QA), and research, thereby simplifying data and improving integration.
Enlitic's technology is designed to enhance the workflow, efficiency, and quality of medical diagnostics at scale. Their models can perform post-read analyses, checking radiology reports against corresponding images to help prevent over or under-called findings. The platform supports healthcare professionals by detecting rare and subtle findings, providing measurements and descriptions, automating longitudinal analysis, and generating reports.
The company primarily serves enterprise health systems, offering solutions that address high-value clinical and operational challenges. Enlitic operates in the healthcare technology market, focusing on improving patient outcomes through advanced diagnostics. The business model revolves around providing AI-powered tools that integrate into various stages of the radiological workflow, thereby enhancing the capabilities of healthcare professionals.
Enlitic generates revenue through the sale and licensing of its AI-powered platform and solutions to healthcare providers and enterprise health systems. By continuously improving its products and services through a Quality Management System framework, Enlitic aims to stay at the forefront of healthcare technology.
Keywords: AI-powered, healthcare, diagnostics, workflow solutions, radiology, data standardization, quality assurance, enterprise health systems, patient outcomes, medical technology.
Company overview
Enlitic company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2014
- Headquarters
- San Francisco, United States
- Employees
- 32
- Open positions
- None listed
- Dealroom signal
- 63.0
- Investment activity
- 1 companies · latest Aug 2024
- Capital deployed
- —
- Preferred round
- ACQUISITION
Valuation & funding
Enlitic funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| POST IPO EQUITYOther financing | Jul 2026 | $9.7M | — | Undisclosed | ↗ |
| POST IPO EQUITYOther financing | Jul 2025 | $2M | — | GE Healthcare | ↗ |
| IPOOther financing | Jan 2024 | $0 | — | Undisclosed | — |
| SERIES BOther financing | Nov 2019 | $25M | $100M | Marubeni · Capitol Health · Amplify Partners · Thorney Investment Group | ↗ |
| SERIES BOther financing | Apr 2019 | $15M | $60M | Marubeni | — |
| SEEDOther financing | Oct 2015 | DCVC · Amplify Partners · Seven Peaks Ventures | — | ||
| SERIES AOther financing | Oct 2015 | Amplify Partners · Capitol Health | — | ||
| SEEDOther financing | Oct 2014 | Amplify Partners · Seven Peaks Ventures | — |
Financials
Revenue and workforce over time
Available revenue and workforce history. Fields without reported data are omitted.
| Year | Revenue | Growth | Employees |
|---|---|---|---|
| 2026 | $3.8M | 0% | 32 |
| 2025 | $3.8M | +251.9% | 43 |
| 2024 | $1.1M | +129.4% | 59 |
| 2023 | $470K | -47.9% | 59 |
| 2022 | $903K | -86.1% | 73 |
| 2021 | $6.5M | +32.7% | 62 |
| 2020 | $4.9M | — | 53 |
Growth signals
Enlitic website traffic
Latest recorded traffic for Enlitic is 9.3K monthly website visits, up 24% over the last three months. Enlitic's team declined 25.6% over the past year.
Comparisons
Enlitic compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Capital deployed
Enlitic investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Talent graph
Enlitic's talent
Source: Dealroom Talent Intelligence.
Investors
13 investors on Enlitic's cap table
Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.
Global footprint
Where Enlitic has talent and traffic
team presence
In the news
Latest news about Enlitic
Recent press, funding announcements, and product moves mentioning Enlitic — open to read from the original sources.
Market sentiment
What the market is saying about Enlitic
An AI-synthesized read of the highest-engagement posts about Enlitic on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Enlitic’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.